HighTower Advisors
ALXN

HighTower Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-16,974
Closed -$3.13M 3152
2021
Q2
$3.13M Buy
16,974
+653
+4% +$120K 0.01% 990
2021
Q1
$2.49M Sell
16,321
-20,891
-56% -$3.19M 0.01% 1020
2020
Q4
$5.81M Buy
37,212
+18,909
+103% +$2.95M 0.02% 544
2020
Q3
$2.09M Buy
18,303
+5,752
+46% +$657K 0.01% 856
2020
Q2
$1.4M Buy
12,551
+7,044
+128% +$787K 0.01% 958
2020
Q1
$495K Buy
+5,507
New +$495K ﹤0.01% 1322
2019
Q4
Sell
-4,299
Closed -$420K 2400
2019
Q3
$420K Sell
4,299
-677
-14% -$66.1K ﹤0.01% 1603
2019
Q2
$655K Buy
4,976
+358
+8% +$47.1K ﹤0.01% 1386
2019
Q1
$628K Buy
4,618
+181
+4% +$24.6K ﹤0.01% 1346
2018
Q4
$431K Sell
4,437
-859
-16% -$83.4K ﹤0.01% 1431
2018
Q3
$739K Buy
5,296
+499
+10% +$69.6K 0.01% 1270
2018
Q2
$592K Buy
4,797
+337
+8% +$41.6K ﹤0.01% 1370
2018
Q1
$493K Sell
4,460
-4
-0.1% -$442 ﹤0.01% 1419
2017
Q4
$535K Sell
4,464
-3,886
-47% -$466K ﹤0.01% 1416
2017
Q3
$1.17M Buy
8,350
+5,363
+180% +$753K 0.01% 1017
2017
Q2
$361K Sell
2,987
-13,070
-81% -$1.58M ﹤0.01% 1528
2017
Q1
$1.93M Sell
16,057
-338
-2% -$40.6K 0.02% 770
2016
Q4
$1.99M Sell
16,395
-1,240
-7% -$150K 0.02% 705
2016
Q3
$2.15M Buy
17,635
+375
+2% +$45.6K 0.02% 640
2016
Q2
$2.03M Sell
17,260
-6,217
-26% -$733K 0.03% 622
2016
Q1
$3.26M Sell
23,477
-4,652
-17% -$647K 0.01% 491
2015
Q4
$5.38M Buy
28,129
+11,222
+66% +$2.14M 0.06% 319
2015
Q3
$2.65M Buy
+16,907
New +$2.65M 0.04% 512
2015
Q2
Sell
-13,124
Closed -$2.27M 1760
2015
Q1
$2.27M Sell
13,124
-4,992
-28% -$865K 0.03% 545
2014
Q4
$3.35M Buy
18,116
+246
+1% +$45.5K 0.05% 405
2014
Q3
$2.96M Sell
17,870
-561
-3% -$93K 0.05% 414
2014
Q2
$2.88M Buy
18,431
+1,211
+7% +$189K 0.05% 436
2014
Q1
$2.62M Buy
17,220
+1,836
+12% +$279K 0.05% 429
2013
Q4
$2.04M Buy
+15,384
New +$2.04M 0.04% 455